Evidence map›Paper›PMID 40512037›Full record

ArticleInfection and immunity2025

A chronic

Mylene Vaillancourt, Sheryl E Fernandes, Diane Aguilar, Anna Clara Milesi Galdino, Peter Jorth

Abstract read
In one paragraph

Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Bridging bench and bedside: translational omics ofEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mylene VaillancourtDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Sheryl E FernandesDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Diane AguilarDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Anna Clara Milesi GaldinoDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Peter JorthDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.ORCID 0000-0002-0981-740X

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Cystic Fibrosis Foundation JORTH17F5,JORTH23I0,JORTH19P0National Institute of Allergy and Infectious Diseases R01AI14642,UL1TR001881NCATS NIH HHS UL1 TR001881
6 · The paper itself

Abstract

Mouse models of cystic fibrosis (CF) have been used to study chronic lung infections; however, these models have lacked the airway mucus that defines human CF pathophysiology and required the use of mucoid

Indexed as

Cystic FibrosisLungMucusPseudomonas aeruginosaPseudomonas InfectionsAnimalsDisease Models, AnimalEpithelial Sodium ChannelsHumansInflammationMiceMice, Inbred C57BLMice, TransgenicEpithelial Sodium ChannelsScnn1b protein, mouseanimal modelscystic fibrosisinflammationlung infectionPseudomonas aeruginosa

Identifiers

PMID40512037
PMCPMC12234440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.